1)日本甲状腺学会,日本内分泌学会(編):甲状腺クリーゼ診療ガイドライン2017,南江堂,2017
2)Satoh T, et al:2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society(First edition). Endocr J 63:1025-1064, 2016
3)Burch HB, Wartofsky L:Life-threatening thyrotoxicosis;Thyroid storm. Endocrinol Metab Clin North Am 22:263-277, 1993
4)Nakamichi A, et al:Manifestation of central diabetes insipidus in a patient with thyroid storm. Intern Med 57:1939-1942, 2018
5)大塚勇輝:致命的なクリーゼへの初期対応,大塚文男(編著):General Mindで攻める 総合内科で診る内分泌疾患,pp224-232,中外医学社,2020
6)Larsen PR:Salicylate-induced increases in free triiodothyronine in human serum.Evidence of inhibition of triiodothyronine binding to thyroxine-binding globulin and thyroxine-binding prealbumin. J Clin Invest 51:1125-1134, 1972
7)田中祐司,他:粘液水腫性昏睡の診断基準と治療方針.日甲状腺会誌4:47-52, 2013
8)大野洋介,他:粘液水腫性昏睡.医学のあゆみ265:128-132, 2018
9)Harada K, et al :Myxedema coma accompanied by sick sinus syndrome and hypoventilation;A case report. J Gen Fam Med 20:206-208, 2019
投与法に苦慮した甲状腺機能低下症の一例.日甲状腺会誌3:41-45, 2012
S静注液200 μg」添付文書,あすか製薬株式会社